-
1
-
-
85047692516
-
Signalling pathways of the TNF superfamily: a double-edged sword
-
COI: 1:CAS:528:DC%2BD3sXmvVWmtb0%3D, PID: 12949498
-
Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3(9):745–56.
-
(2003)
Nat Rev Immunol
, vol.3
, Issue.9
, pp. 745-756
-
-
Aggarwal, B.B.1
-
2
-
-
80054865852
-
TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses
-
COI: 1:CAS:528:DC%2BC3MXhsFagsLzM, PID: 22017434
-
Burkly LC, Michaelson JS, Zheng TS. TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses. Immunol Rev. 2011;244(1):99–114.
-
(2011)
Immunol Rev
, vol.244
, Issue.1
, pp. 99-114
-
-
Burkly, L.C.1
Michaelson, J.S.2
Zheng, T.S.3
-
3
-
-
42949160019
-
The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting
-
COI: 1:CAS:528:DC%2BD1cXlt1agtb0%3D, PID: 18404150
-
Winkles JA. The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov. 2008;7(5):411–25.
-
(2008)
Nat Rev Drug Discov
, vol.7
, Issue.5
, pp. 411-425
-
-
Winkles, J.A.1
-
4
-
-
0031465594
-
TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis
-
COI: 1:CAS:528:DyaK1cXis1Ojug%3D%3D, PID: 9405449
-
Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem. 1997;272(51):32401–10.
-
(1997)
J Biol Chem
, vol.272
, Issue.51
, pp. 32401-32410
-
-
Chicheportiche, Y.1
Bourdon, P.R.2
Xu, H.3
Hsu, Y.M.4
Scott, H.5
Hession, C.6
-
5
-
-
0038320242
-
TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor
-
COI: 1:CAS:528:DC%2BD3sXkt1Ghsrk%3D, PID: 12787562
-
Wiley SR, Winkles JA. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor. Cytokine Growth Factor Rev. 2003;14(3–4):241–9.
-
(2003)
Cytokine Growth Factor Rev
, vol.14
, Issue.3-4
, pp. 241-249
-
-
Wiley, S.R.1
Winkles, J.A.2
-
6
-
-
24644506070
-
The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity
-
COI: 1:CAS:528:DC%2BD2cXltl2nurs%3D, PID: 15353286
-
Campbell S, Michaelson J, Burkly L, Putterman C. The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity. Front Biosci. 2004;9:2273–84.
-
(2004)
Front Biosci
, vol.9
, pp. 2273-2284
-
-
Campbell, S.1
Michaelson, J.2
Burkly, L.3
Putterman, C.4
-
7
-
-
28344457483
-
TWEAK attenuates the transition from innate to adaptive immunity
-
COI: 1:CAS:528:DC%2BD2MXhtlWntLnJ, PID: 16325585
-
Maecker H, Varfolomeev E, Kischkel F, Lawrence D, LeBlanc H, Lee W, et al. TWEAK attenuates the transition from innate to adaptive immunity. Cell. 2005;123(5):931–44.
-
(2005)
Cell
, vol.123
, Issue.5
, pp. 931-944
-
-
Maecker, H.1
Varfolomeev, E.2
Kischkel, F.3
Lawrence, D.4
LeBlanc, H.5
Lee, W.6
-
8
-
-
18244380611
-
A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis
-
COI: 1:CAS:528:DC%2BD3MXptVGgtbY%3D, PID: 11728344
-
Wiley SR, Cassiano L, Lofton T, Davis-Smith T, Winkles JA, Lindner V, et al. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity. 2001;15(5):837–46.
-
(2001)
Immunity
, vol.15
, Issue.5
, pp. 837-846
-
-
Wiley, S.R.1
Cassiano, L.2
Lofton, T.3
Davis-Smith, T.4
Winkles, J.A.5
Lindner, V.6
-
9
-
-
80052858870
-
TWEAK, a multifunctional cytokine in kidney injury
-
COI: 1:CAS:528:DC%2BC3MXhtFyntL7I, PID: 21697814
-
Sanz AB, Sanchez-Niño MD, Ortiz A. TWEAK, a multifunctional cytokine in kidney injury. Kidney Int. 2011;80(7):708–18.
-
(2011)
Kidney Int
, vol.80
, Issue.7
, pp. 708-718
-
-
Sanz, A.B.1
Sanchez-Niño, M.D.2
Ortiz, A.3
-
10
-
-
67349181718
-
Considering TWEAK as a target for therapy in renal and vascular injury
-
COI: 1:CAS:528:DC%2BD1MXnsFaitLk%3D, PID: 19482507
-
Ortiz A, Sanz AB, Muñoz García B, Moreno JA, Sánchez Niño MD, Martín-Ventura JL, et al. Considering TWEAK as a target for therapy in renal and vascular injury. Cytokine Growth Factor Rev. 2009;20(3):251–8.
-
(2009)
Cytokine Growth Factor Rev
, vol.20
, Issue.3
, pp. 251-258
-
-
Ortiz, A.1
Sanz, A.B.2
Muñoz García, B.3
Moreno, J.A.4
Sánchez Niño, M.D.5
Martín-Ventura, J.L.6
-
11
-
-
61449148439
-
TNF-like weak inducer of apoptosis (TWEAK) activates proinflammatory signaling pathways and gene expression through the activation of TGF-beta-activated kinase 1
-
COI: 1:CAS:528:DC%2BD1MXhsFKrsLc%3D, PID: 19201899
-
Kumar M, Makonchuk DY, Li H, Mittal A, Kumar A. TNF-like weak inducer of apoptosis (TWEAK) activates proinflammatory signaling pathways and gene expression through the activation of TGF-beta-activated kinase 1. J Immunol. 2009;182(4):2439–48.
-
(2009)
J Immunol
, vol.182
, Issue.4
, pp. 2439-2448
-
-
Kumar, M.1
Makonchuk, D.Y.2
Li, H.3
Mittal, A.4
Kumar, A.5
-
12
-
-
84884345439
-
Fn14 in podocytes and proteinuric kidney disease
-
PID: 23999007
-
Sanchez-Niño MD, Poveda J, Sanz AB, Mezzano S, Carrasco S, Fernandez-Fernandez B, et al. Fn14 in podocytes and proteinuric kidney disease. Biochim Biophys Acta. 2013;1832(12):2232–43.
-
(2013)
Biochim Biophys Acta
, vol.1832
, Issue.12
, pp. 2232-2243
-
-
Sanchez-Niño, M.D.1
Poveda, J.2
Sanz, A.B.3
Mezzano, S.4
Carrasco, S.5
Fernandez-Fernandez, B.6
-
13
-
-
0033555787
-
Nuclear factor-kappa B p65 mediates the assembly and activation of the TNF-responsive element of the murine monocyte chemoattractant-1 gene
-
COI: 1:CAS:528:DyaK1MXovFOksw%3D%3D, PID: 9916692
-
Ping D, Boekhoudt GH, Rogers EM, Boss JM. Nuclear factor-kappa B p65 mediates the assembly and activation of the TNF-responsive element of the murine monocyte chemoattractant-1 gene. J Immunol. 1999;162(2):727–34.
-
(1999)
J Immunol
, vol.162
, Issue.2
, pp. 727-734
-
-
Ping, D.1
Boekhoudt, G.H.2
Rogers, E.M.3
Boss, J.M.4
-
14
-
-
0033571108
-
The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex
-
COI: 1:CAS:528:DyaK1MXntlKqs74%3D, PID: 10553091
-
Hehner SP, Hofmann TG, Dröge W, Schmitz ML. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. J Immunol. 1999;163(10):5617–23.
-
(1999)
J Immunol
, vol.163
, Issue.10
, pp. 5617-5623
-
-
Hehner, S.P.1
Hofmann, T.G.2
Dröge, W.3
Schmitz, M.L.4
-
15
-
-
44349155996
-
The cytokine TWEAK modulates renal tubulointerstitial inflammation
-
COI: 1:CAS:528:DC%2BD1cXkvFOhsL0%3D, PID: 18235096
-
Sanz AB, Justo P, Sanchez-Niño MD, Blanco-Colio LM, Winkles JA, Kreztler M, et al. The cytokine TWEAK modulates renal tubulointerstitial inflammation. J Am Soc Nephrol. 2008;19(4):695–703.
-
(2008)
J Am Soc Nephrol
, vol.19
, Issue.4
, pp. 695-703
-
-
Sanz, A.B.1
Justo, P.2
Sanchez-Niño, M.D.3
Blanco-Colio, L.M.4
Winkles, J.A.5
Kreztler, M.6
-
16
-
-
11144353779
-
TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages
-
COI: 1:CAS:528:DC%2BD2cXjsVGgsbw%3D, PID: 15056843
-
Kim SH, Kang YJ, Kim WJ, Woo DK, Lee Y, Kim DI, et al. TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages. Circ J. 2004;68(4):396–9.
-
(2004)
Circ J
, vol.68
, Issue.4
, pp. 396-399
-
-
Kim, S.H.1
Kang, Y.J.2
Kim, W.J.3
Woo, D.K.4
Lee, Y.5
Kim, D.I.6
-
17
-
-
34248575149
-
Integrating signals from RTKs to ERK/MAPK
-
COI: 1:CAS:528:DC%2BD2sXlt1Wkt7g%3D, PID: 17496910
-
McKay MM, Morrison DK. Integrating signals from RTKs to ERK/MAPK. Oncogene. 2007;26(22):3113–21.
-
(2007)
Oncogene
, vol.26
, Issue.22
, pp. 3113-3121
-
-
McKay, M.M.1
Morrison, D.K.2
-
18
-
-
0035135929
-
Small GTP-binding proteins
-
COI: 1:CAS:528:DC%2BD3MXitV2ktLw%3D, PID: 11152757
-
Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev. 2001;81(1):153–208.
-
(2001)
Physiol Rev
, vol.81
, Issue.1
, pp. 153-208
-
-
Takai, Y.1
Sasaki, T.2
Matozaki, T.3
-
19
-
-
84903575719
-
Relevant role of PKG in the progression of fibrosis induced by TNF-like weak inducer of apoptosis
-
PID: 24872318
-
Martín P, Mora I, Cortes MA, Calleros L, García-Jerez A, Ortiz A, et al. Relevant role of PKG in the progression of fibrosis induced by TNF-like weak inducer of apoptosis. Am J Physiol Renal Physiol. 2014;307(1):F75–85.
-
(2014)
Am J Physiol Renal Physiol
, vol.307
, Issue.1
, pp. F75-F85
-
-
Martín, P.1
Mora, I.2
Cortes, M.A.3
Calleros, L.4
García-Jerez, A.5
Ortiz, A.6
-
20
-
-
84879595462
-
TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast
-
COI: 1:CAS:528:DC%2BC3sXhtFCgsrjK, PID: 23748045
-
Ucero AC, Benito-Martin A, Fuentes-Calvo I, Santamaria B, Blanco J, Lopez-Novoa JM, et al. TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast. Biochim Biophys Acta. 2013;1832(10):1744–55.
-
(2013)
Biochim Biophys Acta
, vol.1832
, Issue.10
, pp. 1744-1755
-
-
Ucero, A.C.1
Benito-Martin, A.2
Fuentes-Calvo, I.3
Santamaria, B.4
Blanco, J.5
Lopez-Novoa, J.M.6
-
21
-
-
84887506537
-
TWEAK transactivation of the epidermal growth factor receptor mediates renal inflammation
-
COI: 1:CAS:528:DC%2BC3sXhslyhsL7F, PID: 24037740
-
Rayego-Mateos S, Morgado-Pascual JL, Sanz AB, Ramos AM, Eguchi S, Batlle D, et al. TWEAK transactivation of the epidermal growth factor receptor mediates renal inflammation. J Pathol. 2013;231(4):480–94.
-
(2013)
J Pathol
, vol.231
, Issue.4
, pp. 480-494
-
-
Rayego-Mateos, S.1
Morgado-Pascual, J.L.2
Sanz, A.B.3
Ramos, A.M.4
Eguchi, S.5
Batlle, D.6
-
22
-
-
84896347326
-
Interferon regulatory factor 5 and autoimmune lupus
-
PID: 23883595
-
Xu WD, Pan HF, Xu Y, Ye DQ. Interferon regulatory factor 5 and autoimmune lupus. Expert Rev Mol Med. 2013;15:e6.
-
(2013)
Expert Rev Mol Med
, vol.15
, pp. e6
-
-
Xu, W.D.1
Pan, H.F.2
Xu, Y.3
Ye, D.Q.4
-
23
-
-
84856706706
-
Expression of human tumor necrosis factor-like weak inducer of apoptosis in patients with systemic lupus erythematosus
-
COI: 1:CAS:528:DC%2BC38XhslWlsbfJ, PID: 21968693
-
Wang C, Chen LL, Pan HF, Leng RX, Qin WZ, Ye DQ. Expression of human tumor necrosis factor-like weak inducer of apoptosis in patients with systemic lupus erythematosus. Clin Rheumatol. 2012;31(2):335–9.
-
(2012)
Clin Rheumatol
, vol.31
, Issue.2
, pp. 335-339
-
-
Wang, C.1
Chen, L.L.2
Pan, H.F.3
Leng, R.X.4
Qin, W.Z.5
Ye, D.Q.6
-
24
-
-
79251640587
-
Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus
-
COI: 1:CAS:528:DC%2BC3MXhs1ektLg%3D, PID: 21163672
-
Liu ZC, Zhou QL, Li XZ, Yang JH, Ao X, Veeraragoo P, et al. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Cytokine. 2011;53(3):295–300.
-
(2011)
Cytokine
, vol.53
, Issue.3
, pp. 295-300
-
-
Liu, Z.C.1
Zhou, Q.L.2
Li, X.Z.3
Yang, J.H.4
Ao, X.5
Veeraragoo, P.6
-
25
-
-
84863791825
-
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) mediates p38 mitogen-activated protein kinase activation and signal transduction in peripheral blood mononuclear cells from patients with lupus nephritis
-
PID: 22009442
-
Zhi-Chun L, Qiao-Ling Z, Zhi-Qin L, Xiao-Zhao L, Xiao-xia Z, Rong T. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) mediates p38 mitogen-activated protein kinase activation and signal transduction in peripheral blood mononuclear cells from patients with lupus nephritis. Inflammation. 2012;35(3):935–43.
-
(2012)
Inflammation
, vol.35
, Issue.3
, pp. 935-943
-
-
Zhi-Chun, L.1
Qiao-Ling, Z.2
Zhi-Qin, L.3
Xiao-Zhao, L.4
Xiao-xia, Z.5
Rong, T.6
-
26
-
-
75649117077
-
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study
-
PID: 19785730
-
Schwartz N, Rubinstein T, Burkly LC, Collins CE, Blanco I, Su L, et al. Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. Arthritis Res Ther. 2009;11(5):R143.
-
(2009)
Arthritis Res Ther
, vol.11
, Issue.5
, pp. R143
-
-
Schwartz, N.1
Rubinstein, T.2
Burkly, L.C.3
Collins, C.E.4
Blanco, I.5
Su, L.6
-
27
-
-
80755189919
-
Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis
-
COI: 1:CAS:528:DC%2BC3MXhtlagtbnE, PID: 21691937
-
El-Shehaby A, Darweesh H, El-Khatib M, Momtaz M, Marzouk S, El-Shaarawy N, et al. Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis. J Clin Immunol. 2011;31(5):848–56.
-
(2011)
J Clin Immunol
, vol.31
, Issue.5
, pp. 848-856
-
-
El-Shehaby, A.1
Darweesh, H.2
El-Khatib, M.3
Momtaz, M.4
Marzouk, S.5
El-Shaarawy, N.6
-
28
-
-
84863644739
-
Urinary TWEAK level as a marker of lupus nephritis activity in 46 cases
-
PID: 22719208
-
Xuejing Z, Jiazhen T, Jun L, Xiangqing X, Shuguang Y, Fuyou L. Urinary TWEAK level as a marker of lupus nephritis activity in 46 cases. J Biomed Biotechnol. 2012;2012:359647.
-
(2012)
J Biomed Biotechnol
, vol.2012
, pp. 359647
-
-
Xuejing, Z.1
Jiazhen, T.2
Jun, L.3
Xiangqing, X.4
Shuguang, Y.5
Fuyou, L.6
-
29
-
-
79955369269
-
Gene expression of TWEAK/Fn14 and IP-10/CXCR3 in glomerulus and tubulointerstitium of patients with lupus nephritis
-
COI: 1:CAS:528:DC%2BC3MXnsl2isb0%3D
-
Lu J, Kwan BC, Lai FM, Choi PC, Tam LS, Li EK, et al. Gene expression of TWEAK/Fn14 and IP-10/CXCR3 in glomerulus and tubulointerstitium of patients with lupus nephritis. Nephrology (Carlton). 2011;16(4):426–32.
-
(2011)
Nephrology (Carlton)
, vol.16
, Issue.4
, pp. 426-432
-
-
Lu, J.1
Kwan, B.C.2
Lai, F.M.3
Choi, P.C.4
Tam, L.S.5
Li, E.K.6
-
30
-
-
84880955619
-
IL-33 in rheumatoid arthritis: potential role in pathogenesis and therapy
-
COI: 1:CAS:528:DC%2BC3sXhtFeksLzO, PID: 23800433
-
Xu WD, Zhang M, Zhang YJ, Ye DQ. IL-33 in rheumatoid arthritis: potential role in pathogenesis and therapy. Hum Immunol. 2013;74(9):1057–60.
-
(2013)
Hum Immunol
, vol.74
, Issue.9
, pp. 1057-1060
-
-
Xu, W.D.1
Zhang, M.2
Zhang, Y.J.3
Ye, D.Q.4
-
31
-
-
84883185923
-
TWEAK promotes osteoclastogenesis in rheumatoid arthritis
-
COI: 1:CAS:528:DC%2BC3sXhtlyisbvE, PID: 23845567
-
Park JS, Kwok SK, Lim MA, Oh HJ, Kim EK, Jhun JY, et al. TWEAK promotes osteoclastogenesis in rheumatoid arthritis. Am J Pathol. 2013;183(3):857–67.
-
(2013)
Am J Pathol
, vol.183
, Issue.3
, pp. 857-867
-
-
Park, J.S.1
Kwok, S.K.2
Lim, M.A.3
Oh, H.J.4
Kim, E.K.5
Jhun, J.Y.6
-
32
-
-
84865413742
-
TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis
-
COI: 1:CAS:528:DC%2BC38XhtVOqsbnL, PID: 22819243
-
Park JS, Park MK, Lee SY, Oh HJ, Lim MA, Cho WT, et al. TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis. Cytokine. 2012;60(1):143–9.
-
(2012)
Cytokine
, vol.60
, Issue.1
, pp. 143-149
-
-
Park, J.S.1
Park, M.K.2
Lee, S.Y.3
Oh, H.J.4
Lim, M.A.5
Cho, W.T.6
-
33
-
-
45549101861
-
Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis
-
COI: 1:CAS:528:DC%2BD1cXnsVyqsLg%3D, PID: 18465450
-
Park MC, Chung SJ, Park YB, Lee SK. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis. Scand J Rheumatol. 2008;37(3):173–8.
-
(2008)
Scand J Rheumatol
, vol.37
, Issue.3
, pp. 173-178
-
-
Park, M.C.1
Chung, S.J.2
Park, Y.B.3
Lee, S.K.4
-
34
-
-
79953093604
-
TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis
-
COI: 1:CAS:528:DC%2BC3MXksVyjt70%3D, PID: 21435232
-
Dharmapatni AA, Smith MD, Crotti TN, Holding CA, Vincent C, Weedon HM, et al. TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis. Arthritis Res Ther. 2011;13(2):R51.
-
(2011)
Arthritis Res Ther
, vol.13
, Issue.2
, pp. R51
-
-
Dharmapatni, A.A.1
Smith, M.D.2
Crotti, T.N.3
Holding, C.A.4
Vincent, C.5
Weedon, H.M.6
-
35
-
-
73449109162
-
TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade
-
PID: 19147618
-
van Kuijk AW, Wijbrandts CA, Vinkenoog M, Zheng TS, Reedquist KA, Tak PP. TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade. Ann Rheum Dis. 2010;69(1):301–4.
-
(2010)
Ann Rheum Dis
, vol.69
, Issue.1
, pp. 301-304
-
-
van Kuijk, A.W.1
Wijbrandts, C.A.2
Vinkenoog, M.3
Zheng, T.S.4
Reedquist, K.A.5
Tak, P.P.6
-
36
-
-
84882854274
-
Safety, tolerability, pharmacokinetics, and pharmacodynamics of anti-TWEAK monoclonal antibody in patients with rheumatoid arthritis
-
COI: 1:CAS:528:DC%2BC3sXht1aru7vO, PID: 23928094
-
Wisniacki N, Amaravadi L, Galluppi GR, Zheng TS, Zhang R, Kong J, et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of anti-TWEAK monoclonal antibody in patients with rheumatoid arthritis. Clin Ther. 2013;35(8):1137–49.
-
(2013)
Clin Ther
, vol.35
, Issue.8
, pp. 1137-1149
-
-
Wisniacki, N.1
Amaravadi, L.2
Galluppi, G.R.3
Zheng, T.S.4
Zhang, R.5
Kong, J.6
-
37
-
-
70949107842
-
Inflammatory bowel disease
-
COI: 1:CAS:528:DC%2BD1MXhsVequ7bE, PID: 19923578
-
Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361(21):2066–78.
-
(2009)
N Engl J Med
, vol.361
, Issue.21
, pp. 2066-2078
-
-
Abraham, C.1
Cho, J.H.2
-
38
-
-
35348982262
-
Mouse models of inflammatory bowel disease
-
COI: 1:CAS:528:DC%2BD2sXht1ams7fI, PID: 17825455
-
Wirtz S, Neurath MF. Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev. 2007;59(11):1073–83.
-
(2007)
Adv Drug Deliv Rev
, vol.59
, Issue.11
, pp. 1073-1083
-
-
Wirtz, S.1
Neurath, M.F.2
-
39
-
-
81855228077
-
Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis
-
COI: 1:CAS:528:DC%2BC3MXhsFSjt73J, PID: 21893119
-
Kawashima R, Kawamura YI, Oshio T, Son A, Yamazaki M, Hagiwara T, et al. Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis. Gastroenterology. 2011;141(6):2119–29.
-
(2011)
Gastroenterology
, vol.141
, Issue.6
, pp. 2119-2129
-
-
Kawashima, R.1
Kawamura, Y.I.2
Oshio, T.3
Son, A.4
Yamazaki, M.5
Hagiwara, T.6
-
40
-
-
84929307614
-
Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis
-
COI: 1:CAS:528:DC%2BC2MXosFSkt7Y%3D, PID: 25270074
-
Xia Y, Herlitz LC, Gindea S, Wen J, Pawar RD, Misharin A, et al. Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis. J Am Soc Nephrol. 2015;26(5):1053–70.
-
(2015)
J Am Soc Nephrol
, vol.26
, Issue.5
, pp. 1053-1070
-
-
Xia, Y.1
Herlitz, L.C.2
Gindea, S.3
Wen, J.4
Pawar, R.D.5
Misharin, A.6
-
41
-
-
84937630064
-
TWEAK/Fn14 signaling involvement in the pathogenesis of cutaneous disease in the MRL/lpr model of spontaneous lupus
-
COI: 1:CAS:528:DC%2BC2MXnvFWjtLs%3D, PID: 25826425
-
Doerner J, Wen J, Xia Y, Blecher Paz K, Schairer D, Wu L, et al. TWEAK/Fn14 signaling involvement in the pathogenesis of cutaneous disease in the MRL/lpr model of spontaneous lupus. J Invest Dermatol. 2015;135(8):1986–95.
-
(2015)
J Invest Dermatol
, vol.135
, Issue.8
, pp. 1986-1995
-
-
Doerner, J.1
Wen, J.2
Xia, Y.3
Blecher Paz, K.4
Schairer, D.5
Wu, L.6
-
42
-
-
84878353733
-
Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway
-
COI: 1:CAS:528:DC%2BC3sXlslWiu7g%3D, PID: 23578591
-
Wen J, Xia Y, Stock A, Michaelson JS, Burkly LC, Gulinello M, et al. Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway. J Autoimmun. 2013;43:44–54.
-
(2013)
J Autoimmun
, vol.43
, pp. 44-54
-
-
Wen, J.1
Xia, Y.2
Stock, A.3
Michaelson, J.S.4
Burkly, L.C.5
Gulinello, M.6
-
43
-
-
43049176840
-
Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA
-
COI: 1:CAS:528:DC%2BD1cXmslKht7Y%3D
-
Kamijo S, Nakajima A, Kamata K, Kurosawa H, Yagita H, Okumura K. Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA. Rheumatology (Oxford). 2008;47(4):442–50.
-
(2008)
Rheumatology (Oxford)
, vol.47
, Issue.4
, pp. 442-450
-
-
Kamijo, S.1
Nakajima, A.2
Kamata, K.3
Kurosawa, H.4
Yagita, H.5
Okumura, K.6
-
44
-
-
0036196767
-
Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies
-
COI: 1:CAS:528:DC%2BD38Xhsl2rs7o%3D, PID: 11879548
-
Chicheportiche Y, Chicheportiche R, Sizing I, Thompson J, Benjamin CB, Ambrose C, et al. Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies. Arthritis Res. 2002;4(2):126–33.
-
(2002)
Arthritis Res
, vol.4
, Issue.2
, pp. 126-133
-
-
Chicheportiche, Y.1
Chicheportiche, R.2
Sizing, I.3
Thompson, J.4
Benjamin, C.B.5
Ambrose, C.6
-
45
-
-
33750350777
-
Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis
-
COI: 1:CAS:528:DC%2BD28XhtFSns7nI, PID: 17056575
-
Kamata K, Kamijo S, Nakajima A, Koyanagi A, Kurosawa H, Yagita H, et al. Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis. J Immunol. 2006;177(9):6433–9.
-
(2006)
J Immunol
, vol.177
, Issue.9
, pp. 6433-6439
-
-
Kamata, K.1
Kamijo, S.2
Nakajima, A.3
Koyanagi, A.4
Kurosawa, H.5
Yagita, H.6
-
46
-
-
33746890880
-
WEAK is a novel arthritogenic mediator
-
COI: 1:CAS:528:DC%2BD28Xns1Kgs78%3D, PID: 16888023
-
Perper SJ, Browning B, Burkly LC, Weng S, Gao C, Giza K, et al. WEAK is a novel arthritogenic mediator. J Immunol. 2006;177(4):2610–20.
-
(2006)
J Immunol
, vol.177
, Issue.4
, pp. 2610-2620
-
-
Perper, S.J.1
Browning, B.2
Burkly, L.C.3
Weng, S.4
Gao, C.5
Giza, K.6
-
47
-
-
60449110144
-
TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis
-
COI: 1:CAS:528:DC%2BD1MXjslSjur0%3D, PID: 19109961
-
Dohi T, Borodovsky A, Wu P, Shearstone JR, Kawashima R, Runkel L, et al. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis. Gastroenterology. 2009;136(3):912–23.
-
(2009)
Gastroenterology
, vol.136
, Issue.3
, pp. 912-923
-
-
Dohi, T.1
Borodovsky, A.2
Wu, P.3
Shearstone, J.R.4
Kawashima, R.5
Runkel, L.6
-
48
-
-
84901434527
-
Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis
-
COI: 1:CAS:528:DC%2BC2cXhtFOjsr7N, PID: 25022957
-
Dohi T, Kawashima R, Kawamura YI, Otsubo T, Hagiwara T, Amatucci A, et al. Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis. Cytokine. 2014;69(1):14–21.
-
(2014)
Cytokine
, vol.69
, Issue.1
, pp. 14-21
-
-
Dohi, T.1
Kawashima, R.2
Kawamura, Y.I.3
Otsubo, T.4
Hagiwara, T.5
Amatucci, A.6
-
49
-
-
84886029160
-
TWEAK/Fn14 pathway promotes a T helper 2-type chronic colitis with fibrosis in mice
-
COI: 1:CAS:528:DC%2BC3sXjsVOhtL8%3D, PID: 23462911
-
Son A, Oshio T, Kawamura YI, Hagiwara T, Yamazaki M, Inagaki-Ohara K, et al. TWEAK/Fn14 pathway promotes a T helper 2-type chronic colitis with fibrosis in mice. Mucosal Immunol. 2013;6(6):1131–42.
-
(2013)
Mucosal Immunol
, vol.6
, Issue.6
, pp. 1131-1142
-
-
Son, A.1
Oshio, T.2
Kawamura, Y.I.3
Hagiwara, T.4
Yamazaki, M.5
Inagaki-Ohara, K.6
-
50
-
-
7044232143
-
Emerging approaches for the therapy of autoimmune and chronic inflammatory disease
-
COI: 1:CAS:528:DC%2BD2cXptFyjt7s%3D, PID: 15511673
-
Cope AP, Feldmann M. Emerging approaches for the therapy of autoimmune and chronic inflammatory disease. Curr Opin Immunol. 2004;16(6):780–6.
-
(2004)
Curr Opin Immunol
, vol.16
, Issue.6
, pp. 780-786
-
-
Cope, A.P.1
Feldmann, M.2
-
51
-
-
33750390154
-
Immune therapies of autoimmune diseases: are we approaching a real cure?
-
COI: 1:CAS:528:DC%2BD28XhtFens7bO, PID: 17011768
-
Chatenoud L. Immune therapies of autoimmune diseases: are we approaching a real cure? Curr Opin Immunol. 2006;18(6):710–7.
-
(2006)
Curr Opin Immunol
, vol.18
, Issue.6
, pp. 710-717
-
-
Chatenoud, L.1
|